The Efficacy and Safety of Oral Propranolol in Hemangioma of PHACES Syndrome: A Case Report

Abstract

PHACES syndrome is a rare condition characterized by the association of infantile hemangioma with malformations of the posterior fossa of the brain, arterial anomalies of the central nervous system, heart defects, ocular changes and sternal cleft. The use of propranolol in the treatment of infantile hemangioma is well established, but in PHACES syndrome there is still controversy. We use propranolol in this syndrome with good results and safety.